Persistent uncontrolled severe asthma despite widespread biologic use: care gaps from the French FASE2-CPHG real-world study.
BACKGROUND Biologic therapies have transformed the management of severe asthma, yet many patients in routine care remain symptomatic. Most real-world data originate from tertiary centers and may not reflect broader healthcare delivery. OBJECTIVE To describe disease control, exacerbations, adherence, comorbidities, ph...